Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-01-22 @ 9:04 AM
Study NCT ID:
NCT00026494
Status:
COMPLETED
Last Update Posted:
2016-01-18
First Post:
2001-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
01-088
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None